Niranjan Y. Sardesai
Vorstandsvorsitzender bei Geneos Therapeutics, Inc.
Profil
Niranjan Y.
Sardesai is the founder of Nvision Consulting, Inc. (founded in 2005) and Geneos Therapeutics, Inc. (founded in 2017), where he held the titles of President and President & Chief Executive Officer, respectively.
He previously worked as Director-Research & Development at Fujirebio Diagnostics, Inc. (2000-2005), Senior Scientist at IGEN International, Inc., and Senior Vice President-Research & Development at VGX Pharmaceuticals LLC (2006-2009).
From 2012 to 2019, he served as Chief Operating Officer at Inovio Pharmaceuticals, Inc. Dr. Sardesai holds a doctorate from the California Institute of Technology, undergraduate and graduate degrees from the Indian Institute of Technology Bombay, and an MBA from The Wharton School of the University of Pennsylvania.
Aktive Positionen von Niranjan Y. Sardesai
| Unternehmen | Position | Beginn |
|---|---|---|
Geneos Therapeutics, Inc.
 Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Vorstandsvorsitzender | 01.01.2017 |
Ehemalige bekannte Positionen von Niranjan Y. Sardesai
| Unternehmen | Position | Ende |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Geschäftsführer | 21.02.2019 |
VGX Pharmaceuticals LLC
 VGX Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology VGX Pharmaceuticals LLC develops pharmaceuticals. The company was founded by J. Joseph Kim and is headquartered in Blue Bell, PA. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2007 |
| Nvision Consulting, Inc. | Gründer | 01.09.2006 |
Fujirebio Diagnostics, Inc.
 Fujirebio Diagnostics, Inc. Medical SpecialtiesHealth Technology Fujirebio Diagnostics, Inc. develops, manufactures and commercializes in-vitro diagnostic products. Its products include oncology RIA and EIA kits, veterinary products and research kits. The company was founded in 1965 and is headquartered in Malvern, PA | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2005 |
IGEN International, Inc.
 IGEN International, Inc. Medical SpecialtiesHealth Technology IGEN International, Inc. develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing. The company was founded in 1982 and is headquartered in Gaithersburg, MD. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Niranjan Y. Sardesai
| California Institute of Technology | Doctorate Degree |
| Indian Institute of Technology Bombay | Graduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
IGEN International, Inc.
IGEN International, Inc. Medical SpecialtiesHealth Technology IGEN International, Inc. develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing. The company was founded in 1982 and is headquartered in Gaithersburg, MD. | Health Technology |
Fujirebio Diagnostics, Inc.
Fujirebio Diagnostics, Inc. Medical SpecialtiesHealth Technology Fujirebio Diagnostics, Inc. develops, manufactures and commercializes in-vitro diagnostic products. Its products include oncology RIA and EIA kits, veterinary products and research kits. The company was founded in 1965 and is headquartered in Malvern, PA | Health Technology |
VGX Pharmaceuticals LLC
VGX Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology VGX Pharmaceuticals LLC develops pharmaceuticals. The company was founded by J. Joseph Kim and is headquartered in Blue Bell, PA. | Health Technology |
| Nvision Consulting, Inc. | |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Health Technology |
